SCHEMBL982217

SCHEMBL982217

O=C(Cc1cccc(N(CCCN2CCOCC2)C(=O)O)c1)N1CCC(c2cc(Cl)ccc2Cl)=N1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.67
CCR5 P51681 4/20 0.38
TSHR P16473 2/20 0.38
KDM4E B2RXH2 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 1/20 0.38
EPHX2 P34913 1/20 0.38
ORAI1 Q96D31 1/20 0.37
POLB P06746 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
GAA P10253 3/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36
THRB P10828 1/20 0.36
MAPK1 P28482 1/20 0.36
NAMPT P43490 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL981924 0.99 MET (0.66) METCCR5TSHRKDM4ESMN1; SMN2
SCHEMBL12922931 0.80 MET (1.00) METSMN1; SMN2EPHX2POLBALDH1A1
SCHEMBL1427192 0.76 MET (0.65) METTSHRKDM4EEPHX2ALDH1A1
SCHEMBL13580043 0.74 MET (0.58) METKDM4EORAI1POLBALDH1A1
SCHEMBL1427173 0.74 MET (0.58) METKDM4ENPSR1ORAI1SIGMAR1
SCHEMBL983930 0.74 MET (0.58) METNPSR1ORAI1ALDH1A1LMNA
SCHEMBL5046607 0.73 MET (0.68) METTSHRKDM4ESMN1; SMN2ORAI1
Hydrochloric Acid SCHEMBL5050480 0.72 MET (0.67) METTSHRKDM4ESMN1; SMN2ORAI1
SCHEMBL5050486 0.71 MET (0.51) METNPSR1ORAI1ALDH1A1LMNA
SCHEMBL981593 0.71 MET (0.55) METKDM4ESMN1; SMN2NPSR1ORAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7875644-B2 tyrosine kinase inhibitors, in particular Met kinase; antitumor agents;1-(Benzo-1,2,5-thiadiazol-5-ylmethylcarbonyl)-3-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole; leukemia, carcinomas MERCK PATENT GMBH (DE) 2011-01-25 US disclosed